Page last updated: 2024-09-03

l 691831 and 15-hydroxy-5,8,11,13-eicosatetraenoic acid

l 691831 has been researched along with 15-hydroxy-5,8,11,13-eicosatetraenoic acid in 1 studies

Compound Research Comparison

Studies
(l 691831)
Trials
(l 691831)
Recent Studies (post-2010)
(l 691831)
Studies
(15-hydroxy-5,8,11,13-eicosatetraenoic acid)
Trials
(15-hydroxy-5,8,11,13-eicosatetraenoic acid)
Recent Studies (post-2010) (15-hydroxy-5,8,11,13-eicosatetraenoic acid)
50074213110

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Charleson, S; Evans, JF; Léger, S; Perrier, H; Prasit, P; Vickers, PJ; Wang, Z1

Other Studies

1 other study(ies) available for l 691831 and 15-hydroxy-5,8,11,13-eicosatetraenoic acid

ArticleYear
Structural requirements for the binding of fatty acids to 5-lipoxygenase-activating protein.
    European journal of pharmacology, 1994, May-17, Volume: 267, Issue:3

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5-Lipoxygenase-Activating Proteins; Arachidonic Acid; Binding Sites; Carrier Proteins; Humans; Hydroxyeicosatetraenoic Acids; Indoles; Leukocytes; Leukotrienes; Membrane Proteins; Quinolines; Radioligand Assay

1994